Full-Face and Half-Mask Respirator Parts and Accessories
Parts and accessories are available for purchase as separate components to replace worn or damaged parts, or to enhance the features of full-face or half-mask air-purifying respirators (APR).
Replacement parts are necessary components of full-face and half-mask respirators and should be replaced when they are no longer working properly or become damaged. Examples include, but are not limited to, nose cups, inhalation and exhalation valves, head harnesses, and speaking diaphragms.
Accessories are optional enhancements of full-face and half-mask respirators. They are selected based on wearer preference or environment. Examples include, but are not limited to, spectacle kits, lens covers, and adapters.
APR cartridges and filters are independent from this section and are selected based on environment, hazard, and risk.
Regulatory compliance details can be obtained at the individual product level.
MSC Value Collection RCF912 Pack of (500), 9" Long x 12" Wide, Packing List Envelopes Unprinted, Clear
Value Collection RCF912 Pack of (500), 9" Long x 12" Wide, Packing List Envelopes Unprinted, Clear
Biotium Bcl-6 (Follicular Lymphoma Marker) (BCL6/1526), CF647 conjugate, 0.1mg/mL
Bcl-6 is a transcriptional repressor mainly required for germinal center (GC) formation and antibody affinity maturation which has different mechanisms of action specific to the lineage and biological functions. It forms complexes with different corepressors and histone deacetylases to repress the transcriptional expression of different subsets of target genes. Bcl-6 allows GC B-cells to proliferate very rapidly in response to T-cell dependent antigens and tolerate the physiological DNA breaks required for immunglobulin class switch recombination and somatic hypermutation without inducing a p53/TP53-dependent apoptotic response. Antibodies to Bcl-6 are helpful in a number of diagnostic settings, for example in the differential diagnosis of small B-cell lymphoma, and in distinguishing classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma (NLPHL).Primary antibodies are available purified, or with a selection of fluorescent CF Dyes and other labels. CF Dye
Biotium Bcl-6 (Follicular Lymphoma Marker) (BCL6/1527), CF405S conjugate, 0.1mg/mL
Bcl-6 is a transcriptional repressor mainly required for germinal center (GC) formation and antibody affinity maturation which has different mechanisms of action specific to the lineage and biological functions. It forms complexes with different corepressors and histone deacetylases to repress the transcriptional expression of different subsets of target genes. Bcl-6 allows GC B-cells to proliferate very rapidly in response to T-cell dependent antigens and tolerate the physiological DNA breaks required for immunglobulin class switch recombination and somatic hypermutation without inducing a p53/TP53-dependent apoptotic response. Antibodies to Bcl-6 are helpful in a number of diagnostic settings, for example in the differential diagnosis of small B-cell lymphoma, and in distinguishing classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma (NLPHL).Primary antibodies are available purified, or with a selection of fluorescent CF Dyes and other labels. CF Dye
Med Vet International Jorvet Cap and Nozzle, for Henke Drench-Matic Syringe, J0128MD32
Replacement cap and nozzle for Jorvet Henke Drench-Matic syringe.
Waters Corp Waters Module, PrepLC, 40 mm Column Diameter
Waters Module, PrepLC, 40 mm Column Diameter
Cayman Chemical ANTIBODY AV-412 10mg
A dual inhibitor of EGFR and HER2 (IC50s = 1.4, 0.51, 0.79, 2.3, and 19 nM for the EGFR, EGFRL858R, EGFRT790M, EGFRL858R,T790M, and HER2 recombinant intracellular kinase domains, respectively); selective for EGFR and HER2 over IRK, MEK1, PKA, and PKC (IC50s = >10 μM) but also inhibits Abl, FLT1, and Src (IC50s = 41, 920, and 2,000 nM, respectively); induces ubiquitination and degradation of HER2 in SK-BR-3 cells at 10 and 30 μM; decreases levels of HER2 and ERα and increases levels of Hsp70 in MCF-7 cells at 10 μM; inhibits EGF-stimulated growth of A431 cells (IC50 = 0.1 μM); reduces tumor growth in an A431 mouse xenograft model at 10 and 30 mg/kg and in a BT-474 mouse xenograft model at 30 mg/kg
Genscript Corporation CLEC2D hFc ChimeraBiotin Av
C-type lectin domain family 2 member D (CLEC2D) is implicated in the immune response Pre-eclampsia and HIV infection have opposing immune responses The contrasting expression of CLEC2D in HIV infection and pre-eclampsia is demonstrative of the immunosuppressive and pro-inflammatory roles of the respective pathologies